Patients with rheumatoid arthritis (RA) who used GLP-1 receptor agonists had less disease activity and improved ...

GLP-1 receptor agonists may reduce the likelihood of mortality and increase odds for transplant wait-listing for patients ...

Lung cancer patients who take medications called GLP-1 receptor agonists—commonly prescribed for weight loss and diabetes ...

Women taking popular weight-loss medications during their reproductive years may be unaware of associated risks to pregnancy ...

GLP-1 receptor agonists vs other second-line therapies were not associated with an increased thyroid cancer risk among patients with type 2 diabetes.

"Several preclinical and translational data studies suggest potential causative effects on bone health. One study with GLP-1 ...

People taking GLP-1 medications had better-controlled asthma overall, though there was no difference in lung function compared to those not taking GLP-1s. The study suggests that GLP-1 drugs may have ...

Migraines are one of the world's most common neurological conditions, impacting nearly 15% of people globally. Despite this widespread impact, many sufferers find current preventive treatments ...

Patients who are overweight or obese may have a lower risk of developing cancer if they take GLP-1 receptor agonists, data suggest.

Getty Images Associate Professor Luke GrzeskowiakWomen taking popular weight-loss medications during their reproductive years ...